BrainGenetic & Genomic MedicinePeer-reviewed journal article
Long-read sequencing identifies FGF14 repeat expansions in Parkinson's disease
Fulya AkçimeniD, Kensuke DaidaiD, Lara Mariah LangeiD, Abraham G MolleriD, Abigail Miano‐BurkhardtiD, Laksh MalikiD, Kimberly PaquetteiD, Pilar Álvarez JereziD, Jackson Mingle, Breeana BakeriD, Melissa MeredithiD, Cedric KouamiD, Paige JarreauiD, Androo J. Markham, Jessica AndersoniD, Miten JainiD, Mark ChaissoniD, Mark CooksoniD, Bradford H. CaseyiD, Hirotaka IwakiiD, Sara Bandrés‐CigaiD, Paula Saffie AwadiD, Mike A. NallsiD, Zih‐Hua FangiD, Andrew SingletoniD, , Kimberley J BillingsleyiD
- Citations
- 6
- FWCI
- 3.62
- Field percentile
- top 6%
Abstract
Pathogenic GAA repeat expansions in FGF14 are an established cause of late-onset cerebellar ataxia, but have not been linked to Parkinsons disease (PD). Given emerging evidence that repeat expansions in ataxia-associated genes like RFC1, can contribute to atypical or familial forms of PD, we investigated whether FGF14 expansions might play a similar role. Using long-read whole-genome sequencing on 411 individuals with PD and 197 neurologically healthy controls from the PPMI cohort, alongside 1,429 additional controls from the NIH CARD initiative, the 1000 Genomes Project, and the All of Us program, representing globally diverse populations. We identified pathogenic FGF14 GAA repeat expansions in five individuals with PD and one control. All five individuals fit the clinical criteria of PD and showed typical patterns of neurodegeneration on DaTSCAN imaging; -synuclein aggregation was confirmed by a positive seeding assay among four individuals with available data. These findings broaden the phenotypic spectrum of FGF14 repeat-associated disease and suggest a rare, previously unrecognized genetic contributor to PD. To our knowledge, this is the first report implicating FGF14 in PD and underscores the utility of long-read sequencing for detecting hidden forms of pathogenic variation in unresolved cases.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- FGF14 repeat length and mosaic interruptions: modifiers of SCA27B?
Joshua Laß, Mirja Thomsen, … Joanne Trinh·medRxiv·Nov 21, 2024
- Advancing molecular, phenotypic and mechanistic insights of FGF14 pathogenic expansions (SCA27B)
Lars Mohren, Friedrich Erdlenbruch, … Christel Depienne·Nature CommunicationsPeer-reviewed·Sep 3, 2024
- Repeat expansions in Parkinson's disease and parkinsonism across ancestries: insights from a global genetic cohort
Lara Mariah Lange, Catalina Cerquera‐Cleves, … the Global Parkinson’s Genetic Program (GP2)·medRxiv·Jun 22, 2026
- An intronic GAA repeat expansion in FGF14 causes autosomal dominant adult-onset ataxia (SCA50, ATX-FGF14)
Haloom Rafehi, Justin L. Read, … Paul J. Lockhart·The American Journal of Human GeneticsPeer-reviewed·Dec 8, 2022
- Identification of expanded and interrupted ATXN2 repeat expansions in Parkinson's disease cohorts
Longfei Wang, Michael Milton, … Haloom Rafehi·medRxiv·Mar 26, 2025
- Enrichment of Repeat Expansions in FGF14 Associated with Amyotrophic Lateral Sclerosis
Sherie Ma, Phillip K. West, … Masha Strømme·medRxiv·Aug 21, 2026